Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Bio-Rad Laboratories Inc has a consensus price target of $409.43 based on the ratings of 7 analysts. The high is $550 issued by Credit Suisse on August 4, 2023. The low is $315 issued by Jefferies on June 3, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, RBC Capital, and RBC Capital on August 27, 2024, August 16, 2024, and August 2, 2024, respectively. With an average price target of $380.67 between Wells Fargo, RBC Capital, and RBC Capital, there's an implied 15.35% upside for Bio-Rad Laboratories Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Bio-Rad Laboratories (NYSE:BIO) was reported by Wells Fargo on August 27, 2024. The analyst firm set a price target for $340.00 expecting BIO to rise to within 12 months (a possible 3.03% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for Bio-Rad Laboratories (NYSE:BIO) was provided by Wells Fargo, and Bio-Rad Laboratories initiated their equal-weight rating.
There is no last upgrade for Bio-Rad Laboratories
The last downgrade for Bio-Rad Laboratories Inc happened on April 3, 2024 when Citigroup changed their price target from $400 to $365 for Bio-Rad Laboratories Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bio-Rad Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bio-Rad Laboratories was filed on August 27, 2024 so you should expect the next rating to be made available sometime around August 27, 2025.
While ratings are subjective and will change, the latest Bio-Rad Laboratories (BIO) rating was a initiated with a price target of $0.00 to $340.00. The current price Bio-Rad Laboratories (BIO) is trading at is $330.01, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.